Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTE Prophylaxis Regimens in Severe Burn Patients
NCT05237726Completed
- Sponsor
- King Abdullah International Medical Research Center
- Start
- Apr 2020
- Primary completion
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of enoxaparin and heparin in venous thromboembolism (VTE), sponsored by King Abdullah International Medical Research Center. Started Apr 2020; status: completed.
02
Drugs
enoxaparinheparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05237726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05237726.